Victoria Vakiener Arrowhead Pharmaceuticals, Inc. (ARWR) insider trading activity

Victoria Vakiener is Director of ARROWHEAD PHARMACEUTICALS, INC.. Currently has a direct ownership of 35,723 shares of ARWR, which is worth approximately $1.47 Million. The most recent transaction as insider was on Dec 19, 2025, when has been sold 10,040 shares (Common Stock) at a price of $67.66 per share, resulting in proceeds of $679,306. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 35.7K

5.85% 3M change

5.85% 12M change

Total Value Held $1.47 Million

Victoria Vakiener Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 19 2025	SELL Open market or private sale	$679,306 $67.66 p/Share	10,040 Reduced 21.94%	35,723 Common Stock
Dec 16 2025	BUY Grant, award, or other acquisition	-	7,819 Added 14.59%	45,763 Common Stock
Dec 18 2024	BUY Grant, award, or other acquisition	$384,691 $22.99 p/Share	16,733 Added 30.6%	37,944 Common Stock
Dec 16 2024	SELL Open market or private sale	$197,058 $21.91 p/Share	8,994 Reduced 29.78%	21,211 Common Stock
May 02 2024	SELL Open market or private sale	$41,934 $23.31 p/Share	1,799 Reduced 5.62%	30,205 Common Stock
Jan 11 2024	SELL Open market or private sale	$181,059 $38.36 p/Share	4,720 Reduced 12.85%	32,001 Common Stock
Dec 15 2023	BUY Grant, award, or other acquisition	$380,819 $25.41 p/Share	14,987 Added 28.98%	36,721 Common Stock

Sep 28 2023	SELL Open market or private sale	$40,811 $26.33 p/Share	1,550 Reduced 6.66%	21,734 Common Stock
Jan 10 2023	SELL Sale (or disposition) back to the issuer	-	1,764 Reduced 10.27%	15,417 Common Stock
Jan 10 2023	BUY Grant, award, or other acquisition	-	7,867 Added 25.25%	23,284 Common Stock

Also insider at

EPZM

Epizyme, Inc. Healthcare

Chief Commercial Officer

CMRX

CHIMERIX INC Healthcare